Considering that tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent that can induce apoptosis in a wide range of cancers, and the translation of TRAIL into the clinic has been confounded by TRAIL-resistant cancer cell populations [19], we investigated whether CD317 involves in TRAIL-resistant mechanisms. Here, TNF is linked to cancer.